The Effect of Scientific Discovery on Cancer Center Economics
Presented by the American College of Oncology Administrators
Registration is now closed. Thank you to everyone who attended!
Thursday, November 13, 2014
Pacific 10:00 am – 11:00 amMountain 11:00 am – 12:00 pmCentral 12:00 pm – 1:00 pm
Eastern 1:00 pm – 2:00 pm
Members: FREENonmembers: $50
Richard P. Mansour, MD
Scientific discovery drives best practice patterns of care which in turn drives cancer center revenue. Past research studies have determined current patterns of care and research in-progress will determine future patterns of care.
New discoveries will shift the revenue expectations for the cancer care service line. The general categories affected are hospital, radiation center, infusion center, outpatient imaging and outpatient surgical services. This talk will focus on past, present and future scientific discoveries that affect revenue expectations. The emphasis will be on infusion center services.
These trends are emerging:
- New drugs are being studied and released that are shifting primary therapy away from traditional chemotherapy to targeted therapy. The dominant mode of drug delivery for targeted therapy is via the oral route.
- New antibodies directed toward activating the immune system to kill cancer cells are being studied and released. These antibodies are being delivered by the infusion route.
- The role of chemotherapy is at risk being moved from primary medical therapy to secondary and tertiary therapy.
The above trends may have an important financial impact on ambulatory cancer centers.
1. Cancer Center Administrators
2. Cancer Center Personnel
- Infusion Chemotherapy has dominated the outpatient treatment of cancer over the past 30 years
- New drugs that target the specific machinery of cancer replication are being studied and approved
- The new drugs are shifting cancer treatment to the oral route.
- Revenue from Infusion chemotherapy and related services may diminished over the next 25 years.
- Revenue models will gradual change
- A large impact will felt by the at risk accountable care model
- Cancer Center Education will need to re-focus on new drugs with new toxicities
- Patients will be living much longer with more cancer being cured or transformed into a chronic disease
The handouts for this webinar will be sent via email to all registered participants 48 hours prior to the start of the Webinar. Participants can use the handouts to take notes and follow along on the webinar.
Evaluation and Certificate of Attendance
This webinar is worth 1 contact hour. In order to receive credit for participation in an AAMA approved webinar, attendees must be present for the entire session as well as complete and return the evaluation which is sent via e-mail. Once the completed evaluation form has been received in AAMA Headquarters, a personalized Certificate of Attendance will be e-mailed to each participant.
To view the webinar as a group, all members of your group must be registered through the AAMA website at the “Register Online” link above and each person in the group must pay the applicable rate, if it applies. A participant list does not need to be submitted to AAMA as all participants who register at the link above will have access to the evaluation.
All participants must have access to a phone line and an internet connection to GoToWebinar to take advantage of this Webinar. After registering through the AAMA website, attendees must register using the GoToWebinar link available in their confirmation email. Attendees will receive their login information to connect to the webinar after registering in GoToWebinar.
If you have any questions, please call AAMA Headquarters at 312-321-6815 or e-mail at [email protected]